By Melissa Daniels ( May 9, 2017, 4:41 PM EDT) -- A Federal Circuit panel cleared the way Tuesday for generic-drug maker Zydus to bring its version of Shire PLC's gastrointestinal drug Lialda to market, shooting down Shire's argument that a lower court judge unfairly limited the scope of its patent in a long-running infringement suit....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.